StreetAlpha.app
Home › Stocks › BTMD

biote Corp. (BTMD)

$0.99
▲ +3.09%
LAST CLOSE · NOV 17

biote provides a training, software and marketing platform for clinics that treat hormone imbalance, and sells its own dietary supplements. It last closed at $0.99 on Nov 17, up 3.09% on the day.

AI Auto Pilots
Is BTMD in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$178.9M
−8.6% vs a year ago
Net income
−$1.9M
−106.7% vs a year ago
EPS (diluted)
−$0.07
−108.9% vs a year ago
Free cash flow
$7.4M
4.1% margin
Balance sheet
Cash & equivalents
$8.9M
At Sep 30
Debt
$124.2M
At Sep 30
Shareholder equity
−$65.3M
Buybacks
$7.2M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $139.4M$139.4MFY2021FY2022: $165.0M$165.0MFY2022FY2023: $185.4M$185.4MFY2023FY2024: $197.2M$197.2MFY2024FY2025: $192.2M$192.2MFY2025

From BTMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated BTMD in the past 90 days.
Average 12-month target
No price targets on BTMD in the past 90 days.
Latest rating changes
B. Riley SecuritiesMaintained
Aug 10Hold$1.50
TD CowenMaintained
Aug 7Buy$2
DateFirmActionRatingPrice target
Aug 10B. Riley SecuritiesMaintainedHold$1.50
Aug 7TD CowenMaintainedBuy$2
Loading…

Technical Analysis

BTMD · as of the Nov 17 close · updated after every close
Downtrend

The stock is 10% below its 20 day and 18% below its 50 day average. It is 78% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 40). The nearest support is the Pivot S1 at $0.97, and the nearest resistance the Pivot R1 at $1.00.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 9.3%/day
Key levels
$2.9052 week high+192.9%
$1.76200 day average+77.8%
$1.54100 day average+55.6%
$1.23Swing high (Nov 4)+24.2%
$1.1750 day average+18.2%
$1.0920 day average+10.1%
$1.00Pivot R1+1.0%
$0.99Pivot+0.0%
$0.99Last close
$0.97Pivot S1−2.0%
$0.9652 week low−3.0%
Indicators
RSI (14)40.28Middle of its rangeNeutral
MACD-0.05Below its signal lineBearish
Stochastic14.8Near the bottom of its rangeOversold
ADX (14)23.2Weak trend
Williams %R-87.3Oversold below −80, overbought above −20Oversold
CCI (20)-160.6Oversold below −100, overbought above 100Oversold
Rate of change−11.6%Change over 10 sessionsBearish
ATR (14)$0.09Typical daily range, 9.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for BTMD

What happened before

See how BTMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow BTMD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How BTMD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in BTMD in the last 90 days.

Loading…

See today’s whale options flow across the market →

BTMD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼9 buying vs 57 selling
  • ▼Shares held by funds -25.0%
  • ▼Funds holding -16
  • ▼Superinvestors: 1 added, 3 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding5672−22.2%
In funds' top 10110.0%
Held by funds–––
New / increased6 / 315 / 25−77.5%
Reduced / sold out35 / 2220 / 26+23.9%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BTMD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BTMD is in one of them and how their past BTMD trades turned out.

BTMD in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BTMD in an article yet. Here's the latest on the wider market.

About biote

biote is based in Irving, Texas, and runs a practice-building platform for clinics that treat hormone imbalance. The platform gives certified practitioners training, certification, practice management and inventory software, and marketing support. Clinics pay fees for the program, and biote also sells its own line of dietary supplements through the same practitioner network. Its customers are mainly physicians and clinics focused on treating symptoms of menopause and male hormone decline.

Headquarters
Irving, TX